A4Cell ha conseguido una nueva ampliación de 1,2M€

A4Celll, company dedicated to produce small silicon nanodevices for monitoring living single cells, has accomplished this third round of funding with the contribution of BeAble Capital and @CDTIoficial Centro para el Desarrollo Tecnológico Industrial .This event will allow A4Cell to reach immediate business challenges and goals required to launch `Cytocheck SPAchip Detection Kits’ to High Content Screening market in next 2022 year.

We are very grateful and proud for support received from our investors.

#AyudasCDTI  #innovación  #pymes  #pymesinnovadoras  #tecnología  #biotechnology  #HCS  #nanotechnology